Literature DB >> 1972126

Omeprazole in H2 blocker non-responders.

V Savarino, G Mela, A Sumberaz, G Celle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1972126      PMCID： PMC1378583          DOI： 10.1136/gut.31.5.584-a

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Omeprazole v ranitidine.

Authors:  C M Bate
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

2.  Omeprazole in peptic ulcers resistant to histamine H2-receptor antagonists.

Authors:  G N Tytgat; C B Lamers; W Hameeteman; J M Jansen; J A Wilson
Journal:  Aliment Pharmacol Ther       Date:  1987-02       Impact factor: 8.171

3.  Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study.

Authors:  V Savarino; G S Mela; P Zentilin; M R Magnolia; P Scalabrini; F Valle; M Moretti; G Bonifacino; G Celle
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

4.  Nocturnal doses of H2 receptor antagonists for duodenal ulcer.

Authors:  C W Howden; D B Jones; R H Hunt
Journal:  Lancet       Date:  1985-03-16       Impact factor: 79.321

5.  Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.

Authors:  S Lanzon-Miller; R E Pounder; M R Hamilton; S Ball; N A Chronos; F Raymond; M Olausson; C Cederberg
Journal:  Aliment Pharmacol Ther       Date:  1987-06       Impact factor: 8.171

6.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

Review 7.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

8.  Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.

Authors:  G Brunner; W Creutzfeldt; U Harke; R Lamberts
Journal:  Digestion       Date:  1988       Impact factor: 3.216

9.  Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.

Authors:  J C Delchier; J P Isal; S Eriksson; J C Soule
Journal:  Gut       Date:  1989-09       Impact factor: 23.059
  9 in total
  2 in total

1.  H2 antagonist and omeprazole nonresponders.

Authors:  V Savarino; G S Mela; S Vigneri; G Celle
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 2.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.